These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 31277130

  • 1. Women successfully treated for severe intrahepatic cholestasis of pregnancy do not have increased risks for adverse perinatal outcomes.
    Yang J, Chen C, Liu M, Zhang S.
    Medicine (Baltimore); 2019 Jul; 98(27):e16214. PubMed ID: 31277130
    [Abstract] [Full Text] [Related]

  • 2. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
    Chappell LC, Chambers J, Dixon PH, Dorling J, Hunter R, Bell JL, Bowler U, Hardy P, Juszczak E, Linsell L, Rounding C, Smith A, Williamson C, Thornton JG.
    Trials; 2018 Nov 27; 19(1):657. PubMed ID: 30482254
    [Abstract] [Full Text] [Related]

  • 3. Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy.
    Kawakita T, Parikh LI, Ramsey PS, Huang CC, Zeymo A, Fernandez M, Smith S, Iqbal SN.
    Am J Obstet Gynecol; 2015 Oct 27; 213(4):570.e1-8. PubMed ID: 26071912
    [Abstract] [Full Text] [Related]

  • 4. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations.
    Vasavan T, Deepak S, Jayawardane IA, Lucchini M, Martin C, Geenes V, Yang J, Lövgren-Sandblom A, Seed PT, Chambers J, Stone S, Kurlak L, Dixon PH, Marschall HU, Gorelik J, Chappell L, Loughna P, Thornton J, Pipkin FB, Hayes-Gill B, Fifer WP, Williamson C.
    J Hepatol; 2021 May 27; 74(5):1087-1096. PubMed ID: 33276032
    [Abstract] [Full Text] [Related]

  • 5. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe.
    Ambros-Rudolph CM, Glatz M, Trauner M, Kerl H, Müllegger RR.
    Arch Dermatol; 2007 Jun 27; 143(6):757-62. PubMed ID: 17576942
    [Abstract] [Full Text] [Related]

  • 6. Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid.
    Joutsiniemi T, Timonen S, Linden M, Suvitie P, Ekblad U.
    BMC Gastroenterol; 2015 Jul 29; 15():92. PubMed ID: 26215400
    [Abstract] [Full Text] [Related]

  • 7. The concentrations of bile acids and erythropoietin in pregnant women with intrahepatic cholestasis and the state of the fetus and newborn.
    Kowalska-Kańka A, Maciejewski T, Niemiec KT.
    Med Wieku Rozwoj; 2013 Jul 29; 17(3):232-45. PubMed ID: 24296447
    [Abstract] [Full Text] [Related]

  • 8. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.
    Chappell LC, Bell JL, Smith A, Linsell L, Juszczak E, Dixon PH, Chambers J, Hunter R, Dorling J, Williamson C, Thornton JG, PITCHES study group.
    Lancet; 2019 Sep 07; 394(10201):849-860. PubMed ID: 31378395
    [Abstract] [Full Text] [Related]

  • 9. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid.
    Grymowicz M, Czajkowski K, Smolarczyk R.
    Scand J Gastroenterol; 2016 Jan 07; 51(1):78-85. PubMed ID: 26152830
    [Abstract] [Full Text] [Related]

  • 10. New Insights on Intrahepatic Cholestasis of Pregnancy.
    Floreani A, Gervasi MT.
    Clin Liver Dis; 2016 Feb 07; 20(1):177-89. PubMed ID: 26593298
    [Abstract] [Full Text] [Related]

  • 11. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).
    Kong X, Kong Y, Zhang F, Wang T, Yan J.
    Medicine (Baltimore); 2016 Oct 07; 95(40):e4949. PubMed ID: 27749550
    [Abstract] [Full Text] [Related]

  • 12. Clinical value of maternal bile Acid quantification in intrahepatic cholestasis of pregnancy as an adverse perinatal outcome predictor.
    Garcia-Flores J, Cañamares M, Cruceyra M, Garicano A, Espada M, Lopez A, Tamarit I.
    Gynecol Obstet Invest; 2015 Oct 07; 79(4):222-8. PubMed ID: 25720981
    [Abstract] [Full Text] [Related]

  • 13. Intrahepatic Cholestasis of Pregnancy: A Review of Diagnosis and Management.
    Wood AM, Livingston EG, Hughes BL, Kuller JA.
    Obstet Gynecol Surv; 2018 Feb 07; 73(2):103-109. PubMed ID: 29480924
    [Abstract] [Full Text] [Related]

  • 14. Increased syndecan-1 and glypican-3 predict poor perinatal outcome and treatment resistance in intrahepatic cholestasis.
    Gümüş Güler B, Özler S.
    Hepatobiliary Pancreat Dis Int; 2020 Jun 07; 19(3):271-276. PubMed ID: 31919038
    [Abstract] [Full Text] [Related]

  • 15. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy.
    Brites D, Rodrigues CM, Oliveira N, Cardoso M, Graça LM.
    J Hepatol; 1998 Jan 07; 28(1):91-8. PubMed ID: 9537870
    [Abstract] [Full Text] [Related]

  • 16. Role of ursodeoxycholic acid on maternal serum bile acids and perinatal outcomes in intrahepatic cholestasis of pregnancy.
    Roy A, Premkumar M, Mishra S, Mehtani R, Suri V, Aggarwal N, Singh S, Dhiman RK.
    Eur J Gastroenterol Hepatol; 2021 Apr 01; 33(4):571-576. PubMed ID: 33136720
    [Abstract] [Full Text] [Related]

  • 17. Enzymatic quantification of total serum bile acids as a monitoring strategy for women with intrahepatic cholestasis of pregnancy receiving ursodeoxycholic acid treatment: a cohort study.
    Manna LB, Ovadia C, Lövgren-Sandblom A, Chambers J, Begum S, Seed P, Walker I, Chappell LC, Marschall HU, Williamson C.
    BJOG; 2019 Dec 01; 126(13):1633-1640. PubMed ID: 31483939
    [Abstract] [Full Text] [Related]

  • 18. Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels.
    Brouwers L, Koster MP, Page-Christiaens GC, Kemperman H, Boon J, Evers IM, Bogte A, Oudijk MA.
    Am J Obstet Gynecol; 2015 Jan 01; 212(1):100.e1-7. PubMed ID: 25046809
    [Abstract] [Full Text] [Related]

  • 19. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.
    Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Ilio C, Chambers J, Kohari K, Bacq Y, Bozkurt N, Brun-Furrer R, Bull L, Estiú MC, Grymowicz M, Gunaydin B, Hague WM, Haslinger C, Hu Y, Kawakita T, Kebapcilar AG, Kebapcilar L, Kondrackienė J, Koster MPH, Kowalska-Kańka A, Kupčinskas L, Lee RH, Locatelli A, Macias RIR, Marschall HU, Oudijk MA, Raz Y, Rimon E, Shan D, Shao Y, Tribe R, Tripodi V, Yayla Abide C, Yenidede I, Thornton JG, Chappell LC, Williamson C.
    Lancet; 2019 Mar 02; 393(10174):899-909. PubMed ID: 30773280
    [Abstract] [Full Text] [Related]

  • 20. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy.
    Binder T, Salaj P, Zima T, Vítek L.
    J Perinat Med; 2006 Mar 02; 34(5):383-91. PubMed ID: 16965225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.